Back to 
Capital International Investors
Capital International Investors
SGEN
Showing 0 of 9 quarters
Position history for Capital International Investors's holdings in SEATTLE GENETICS INC
As of its Q3 2020 13F, Capital International Investors held 18,636,304 shares of SGEN (Seattle Genetics), worth $3.6B. Capital International Investors' 13F filings listed SGEN from Q4 2018 to Q3 2020, 8 quarterly filings. SGEN was 1.1% of Capital International Investors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.